Your session is about to expire
← Back to Search
Other
Tourniquet Use for Ankle Fracture Surgery
N/A
Recruiting
Led By Lara Atwater, MD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult patients (18 years to 89 years) undergoing surgical ankle fracture fixation at OHSU
Be older than 18 years old
Must not have
History of other significant long bone or internal injuries (including ipsilateral limb injuries)
History of sepsis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed preoperatively and at 2 hours and 3, 6 and 12 weeks postoperatively
Awards & highlights
Summary
This trial looks at the effects of using a tourniquet during surgery on muscle function and patient recovery afterwards.
Who is the study for?
Adults aged 18 to 89 who are having surgery for an ankle fracture at OHSU can join this trial. It's not for those with other major bone or internal injuries, including on the same limb, or people with sepsis.Check my eligibility
What is being tested?
The study is looking at how using a tourniquet during ankle surgery affects muscle pH levels and if there's any link between its use and how well patients recover functionally and what they report about their outcomes after surgery.See study design
What are the potential side effects?
While specific side effects aren't listed, tourniquets may cause discomfort, temporary numbness, swelling in the operated limb, or skin marks where applied.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 89 years old and having surgery for an ankle fracture at OHSU.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had serious injuries to my bones or internal organs.
Select...
I have had sepsis before.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ assessed preoperatively and at 2 hours and 3, 6 and 12 weeks postoperatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed preoperatively and at 2 hours and 3, 6 and 12 weeks postoperatively
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Foot and Ankle Ability Measure
Pain
Patient-Reported Outcomes Measurement Information System Physical Function Subscale
Secondary outcome measures
Ankle range of motion
Calf girth
Fatigability
+7 moreTrial Design
2Treatment groups
Active Control
Group I: TourniquetActive Control1 Intervention
This arm will have a tourniquet placed around the thigh inflated to 250mmHg for the duration of surgery (until splint placed) or 2 hours, whichever is shorter, during ankle fracture surgery.
Group II: No TourniquetActive Control1 Intervention
This arm will have a tourniquet placed around the thigh but NOT inflated for the duration of ankle fracture surgery.
Find a Location
Who is running the clinical trial?
Oregon Health and Science UniversityLead Sponsor
985 Previous Clinical Trials
7,385,334 Total Patients Enrolled
Lara Atwater, MDPrincipal InvestigatorOregon Health and Science University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had serious injuries to my bones or internal organs.I have had sepsis before.I am between 18 and 89 years old and having surgery for an ankle fracture at OHSU.
Research Study Groups:
This trial has the following groups:- Group 1: Tourniquet
- Group 2: No Tourniquet
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger